164
Participants
Start Date
January 26, 2021
Primary Completion Date
January 2, 2024
Study Completion Date
February 22, 2024
apraglutide
Apraglutide is a peptide analogue of GLP-2 under development for treatment of SBS-IF, which acts as a full agonist at the GLP-2 receptor with in vitro potency and selectivity comparable with native GLP-2.
Far Eastern Memorial Hospital, New Taipei City
Medical Centre, Hungarian Defence Forces, Budapest
Semmelweis University, Budapest
University Hospital Brussels, Brussels
Rigshospitalet - University Hospital Copenhagen, Copenhagen
Universitair Ziekenhuis Leuven - Gasthuisberg, Leuven
Alesund Hospital, Ålesund
Hôpital ARCHET II, Nice
University of Szeged, Szeged
Mount Sinai Medical Center, New York
University Hospital Kralovske Vinohrady, 2nd Internal Clinic, Prague
Charité - Universitätsmedizin Berlin, Berlin
Citta della salute e della Scienza di Torino Hospital, Torino
General University Hospital in Prague, Prague
Hospital of the University of Pennsylvania, Philadelphia
Asklepios Klinik St. Georg, Hamburg
Duke University Hospital, Durham
University General Hospital Gregorio Maranon, Madrid
University Hospital 12 de Octubre, Madrid
University Hospital Plzen, Pilsen
Rambam Health Care Campus, Haifa
Hôpital Haut-Lévèque, Pessac
Gastroenterology Group of Naples, Naples
Vanderbilt University Medical Center, Center for Human Nutrition, Nashville
Polyclinic S. Orsola-Malpighi, Bologna
University Hospital Virgen del Rocio, Seville
Sahlgrenska University Hospital, Gothenburg
CHU Hôtel Dieu, Nantes
Cleveland Clinic Foundation, Cleveland
University Hospital Muenster, Münster
Henry Ford Medical Center - Columbus, Novi
Rabin Medical Center, Petah Tikva
University Hospital Hradec Kralove, Hradec Králové
University Hospital Bonn, Bonn
Brabois Adults Hospital, Vandœuvre-lès-Nancy
Mayo Clinic, Rochester
Northwestern University, Chicago
University Hospital Brno, Brno
University of Nebraska Medical Center, Omaha
University Hospital Heidelberg, Heidelberg
Hospices Civils de Lyon, Pierre-Bénite
Ronald Reagan UCLA Medical Center, Los Angeles
Hôpital Beaujon, Clichy
University of Washington Medical Center, Seattle
Sheba Medical Center, Tel Litwinsky
Cincinnati Children's Hospital Medical Center, Cincinnati
University Hospital Foundation Favaloro, Buenos Aires
University College Hospital, London
Salford Royal Hospital, Salford
Hospital Novy Jicin, Nový Jičín
St. Imre University Teaching Hospital Budapest, Budapest
"University Polyclinic Foundation Agostino Gemelli - IRCCS", Rome
Yokohama Municipal Citizen's Hospital, Kanagawa
Asan Medical Center, Soeul
Yokohama City University Medical Center, Kanagawa
National University Corportation Tohoku University Tohoku University Hospital, Miyagi
Osaka University Hospital, Osaka
JCHO Tokyo Yamate Medical Center, Tokyo
Stadmedica, Non-Public Healthcare Facility, Bydgoszcz
COPERNICUS Limited Liability Company, Gdansk
M. Pirogow Provincial Specialized Hospital, Lodz
Gastromed Poland Sp. z o.o., Lublin
Stanley Dudrick Multispecialty Hospital, Skawina
The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul
Samsung Medical Center, Soeul
University Hospitals Birmingham NHS Foundation Trust, Birmingham
St Mark's Hospital, Harrow
Royal London Hospital, London
VectivBio AG
INDUSTRY